Literature DB >> 12634375

nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.

Chie Sugimoto1, Kei Tadakuma, Isao Otani, Takashi Moritoyo, Hirofumi Akari, Fumiko Ono, Yasuhiro Yoshikawa, Tetsutaro Sata, Shuji Izumo, Kazuyasu Mori.   

Abstract

The pathogenesis of AIDS virus infection in a nonhuman primate AIDS model was studied by comparing plasma viral loads, CD4(+) T-cell subpopulations in peripheral blood mononuclear cells, and simian immunodeficiency virus (SIV) infection in lymph nodes for rhesus macaques infected with a pathogenic molecularly cloned SIVmac239 strain and those infected with its nef deletion mutant (Deltanef). In agreement with many reports, whereas SIVmac239 infection induced AIDS and depletion of memory CD4(+) T cells in 2 to 3 years postinfection (p.i.), Deltanef infection did not induce any manifestation associated with AIDS up to 6.5 years p.i. To explore the difference in SIV infection in lymphoid tissues, we biopsied lymph nodes at 2, 8, 72, and 82 weeks p.i. and analyzed them by pathological techniques. Maximal numbers of SIV-infected cells (SIV Gag(+), Env(+), and RNA(+)) were detected at 2 weeks p.i. in both the SIVmac239-infected animals and the Deltanef-infected animals. In the SIVmac239-infected animals, most of the infected cells were localized in the T-cell-rich paracortex, whereas in the Deltanef-infected animals, most were localized in B-cell-rich follicles and in the border region between the paracortex and the follicles. Analyses by double staining of CD68(+) macrophages and SIV Gag(+) cells and by double staining of CD3(+) T cells and SIV Env(+) cells revealed that SIV-infected cells were identified as CD4(+) T cells in either the SIVmac239 or the Deltanef infection. Whereas the many functions of Nef protein were reported from in vitro studies, our finding of SIVmac239 replication in the T-cell-rich paracortex in the lymph nodes supports the reported roles of Nef protein in T-cell activation and enhancement of viral infectivity. Furthermore, the abundance of SIVmac239 infection and the paucity of Deltanef infection in the T-cell-rich paracortex accounted for the differences in viral replication and pathogenicity between SIVmac239 and the Deltanef mutant. Thus, our in vivo study indicated that the nef gene enhances SIV replication by robust productive infection in memory CD4(+) T cells in the T-cell-rich region in lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634375      PMCID: PMC150654          DOI: 10.1128/jvi.77.7.4169-4180.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

4.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Accumulation of MAC387+ macrophages in paracortical areas of lymph nodes in rhesus monkeys acutely infected with simian immunodeficiency virus.

Authors:  I Otani; K Mori; T Sata; K Terao; K Doi; H Akari; Y Yoshikawa
Journal:  Microbes Infect       Date:  1999-10       Impact factor: 2.700

6.  The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cellsand T cells.

Authors:  D Messmer; R Ignatius; C Santisteban; R M Steinman; M Pope
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

Authors:  K Mori; Y Yasutomi; S Sawada; F Villinger; K Sugama; B Rosenwith; J L Heeney; K Uberla; S Yamazaki; A A Ansari; H Rübsamen-Waigmann
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  T Moritoyo; S Izumo; H Moritoyo; Y Tanaka; Y Kiyomatsu; M Nagai; K Usuku; M Sorimachi; M Osame
Journal:  J Neurovirol       Date:  1999-06       Impact factor: 2.643

10.  Induction of protective immunity against pathogenic simian immunodeficiency virus by a foreign receptor-dependent replication of an engineered avirulent virus.

Authors:  T Matano; M Kano; T Odawara; H Nakamura; A Takeda; K Mori; T Sato; Y Nagai
Journal:  Vaccine       Date:  2000-08-01       Impact factor: 3.641

View more
  20 in total

1.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

2.  Vaccine protection by live, attenuated simian immunodeficiency virus in the absence of high-titer antibody responses and high-frequency cellular immune responses measurable in the periphery.

Authors:  Keith Mansfield; Sabine M Lang; Marie-Claire Gauduin; Hannah B Sanford; Jeffrey D Lifson; R Paul Johnson; Ronald C Desrosiers
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

Review 3.  Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Authors:  Oliver T Fackler; Thomas T Murooka; Andrea Imle; Thorsten R Mempel
Journal:  Nat Rev Microbiol       Date:  2014-08       Impact factor: 60.633

4.  Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.

Authors:  Masayuki Fujino; Hirotaka Sato; Tomotaka Okamura; Akihiko Uda; Satoshi Takeda; Nursarat Ahmed; Shigeyuki Shichino; Teiichiro Shiino; Yohei Saito; Satoru Watanabe; Chie Sugimoto; Marcelo J Kuroda; Manabu Ato; Yoshiyuki Nagai; Shuji Izumo; Kouji Matsushima; Masaaki Miyazawa; Aftab A Ansari; Francois Villinger; Kazuyasu Mori
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.

Authors:  Bettina Stolp; Andrea Imle; Fernanda Matos Coelho; Miroslav Hons; Roser Gorina; Ruth Lyck; Jens V Stein; Oliver T Fackler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

6.  Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling.

Authors:  Bettina Stolp; Libin Abraham; Jochen M Rudolph; Oliver T Fackler
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

7.  HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes.

Authors:  Cinzia Nobile; Dominika Rudnicka; Milena Hasan; Nathalie Aulner; Françoise Porrot; Christophe Machu; Olivier Renaud; Marie-Christine Prévost; Claire Hivroz; Olivier Schwartz; Nathalie Sol-Foulon
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

Authors:  Tasha Biesinger; Robert White; Monica T Yu Kimata; Brenda K Wilson; Jonathan S Allan; Jason T Kimata
Journal:  Retrovirology       Date:  2010-10-13       Impact factor: 4.602

9.  Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.

Authors:  Chie Sugimoto; Satoru Watanabe; Taeko Naruse; Eiji Kajiwara; Teiichiro Shiino; Natsuko Umano; Kayoko Ueda; Hirotaka Sato; Shinji Ohgimoto; Vanessa Hirsch; Francois Villinger; Aftab A Ansari; Akinori Kimura; Masaaki Miyazawa; Yasuo Suzuki; Naoki Yamamoto; Yoshiyuki Nagai; Kazuyasu Mori
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

10.  Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo.

Authors:  W David Wick; Peter B Gilbert; Otto O Yang
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.